We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Clears Alpharma's Generic Neurontin

Law360 (October 13, 2004, 12:00 AM EDT) -- A federal district court judge has denied drug maker Pfizer Inc.'s motion for a preliminary injunction to block Alpharma's sale of a generic version of epilepsy drug Neurontin.

Alpharma said Friday it was launching its Neurontin generic after hearings in the U.S. District Court for New Jersey ended without a ruling. Pfizer responded by launching its own generic capsules in the same 100 milligram, 300 milligram and 400 milligram doses as Alpharma.

U.S. District Court Judge John Liftland has scheduled hearings for mid-November for oral arguments...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.